Online: | |
Visits: | |
Stories: |
by Alex Thomas, Intellihub:
The medical uses of cannabis and its derivatives are continuing to be discovered at an astonishing rate. This is despite the fact that U.S. government clings to an absurd, baseless classification of cannabis as a Schedule I drug, which severely limits research and scientific advancement.
We can add bone fractures and organ transplants to the diverse list of conditions that medicinal cannabis can treat.
A study performed by Tel Aviv University and Hebrew University researchers finds that the non-psychotropic component cannabinoid cannabidiol (CBD) helps heal bone fractures.
They administered the compound to rats with mid-femoral fractures and found that it “markedly enhanced the healing process of the femora after just eight weeks.”
The team had found in earlier research that our bodies’ cannabinoid receptors stimulate bone formation and inhibit bone loss. It was a natural progression to test how this can be utilized to aid bone healing.
“The clinical potential of cannabinoid-related compounds is simply undeniable at this point,” said Dr. Gabet. “While there is still a lot of work to be done to develop appropriate therapies, it is clear that it is possible to detach a clinical therapy objective from the psychoactivity of cannabis. CBD, the principal agent in our study, is primarily anti-inflammatory and has no psychoactivity.”